Emmes
Delivering Global Health Impact Through People, Science and Technology
Rockville, United States · Founded 1977 · $800.0M raised
- Headquarters
- Rockville, Maryland
- Employees
- 201–500
- Founded
- 1977
- Business Model
- B2B
- Website
- theemmesgroup.com
- Total Funding
- $800.0M
- Last Round
- $800.0M Private EquityJun 2022
- Rounds
- 1
About
Emmes Group is a global, tech-enabled full-service contract research organization (CRO) founded in 1977 and headquartered in Rockville, Maryland. The company specializes in clinical research services across vaccines, ophthalmology, neuroscience, rare disease, and cell and gene therapy, serving both government and commercial biopharma clients. Its Veridix platform provides AI-powered eClinical tools including EDC, decentralized trials, and biostatistics agents.
Summary
Emmes is a Healthcare company based in Rockville, United States, founded in 1977. It has raised $800.0M in total across 1 round, most recently a $800.0M Private Equity round in Jun 2022. Investors include New Mountain Capital.
Tech & App Stack
6 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2022
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
BridgeBio makes targeted treatments for genetic diseases.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...